Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

JAK inhibitors effectively regrow hair in children with alopecia areata and are safe to use.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Upadacitinib may effectively treat resistant lichen planopilaris.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Finasteride reduces movement issues in Parkinson's disease rats.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

New hybrid compound found to effectively prevent hair loss.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Deoxyshikonin helps wounds heal faster in diabetic mice.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.